The Barcelona clinic liver cancer (BCLC) algorithm is the most widely accepted staging system form hepatocellular carcinoma (HCC). Liver resection is traditionally proposed to early stage HCC (BCLC-0/A), even if recent reports have shown that surgical resection could provide a safe and effective treatment also for intermediate-stage HCC (BCLC-B). In this study, we focused on surgical and oncological outcomes of hepatic resection in BLCB-B patients. Patients who received hepatic resection for early- (BCLC-0/A) or intermediate-stage (BCLC-B) HCC in two tertiary hepatobiliary centers between January 2003 and December 2016 were included in study. Four-hundred and twenty-nine patients were included in the analysis. At the time of resection, 298 patients were classified as BCLC-A/0 and 131 as BCLC-B. Despite a higher complication rate in BCLC-B group (49.6% vs 32.9%; p = 0.001), the incidence of clinically relevant complications did not differ significantly between the two groups (16.0% vs 10.1%; p = 0.079); moreover, postoperative mortality (4.6% vs 2.7%; p = 0.309) and relapse-free survival (RFS) were similar between BCLC-0/A and BCLC-B group (1-, 3-, and 5-year RFS: 74, 43, and 31% vs 59, 38, and 34%; p = 0.180). Overall survival was slightly worse in BCLC-B group (1-, 3-, and 5-year overall survival of 89, 70, and 52% vs. 77, 51, and 44%; p = 0.004). Focusing on BCLC-B group, a Child–Pugh score B (HR 2.47; p = 0.003), growing number of nodules (HR 3.04; p = 0.003), and R1 resection (HR 2.43; p = 0.005) beard a higher risk of tumor recurrence, while overall survival was negatively affected by the presence of more than two nodules (HR 3.66; p = 0.0001) and R1 resection (HR 3.06; p = 0.0001); patients presenting single-large HCC experienced a better overall survival (HR 0.53; p = 0.014) and lower recurrence-rate (HR 0.60; p = 0.046). Hepatic resection for intermediate-stage HCC shows acceptable results in terms of perioperative morbidity and mortality, with better oncological outcomes in patients with lower number of lesions despite of their size.
Hepatocellular carcinoma BCLC Liver resection Liver surgery
Barcelona clinic liver cancer
Magnetic resonance imaging
This is a preview of subscription content, log in to check access.
We thank the NTF Research Group, Enrico Pinotti MD [MONZA], Laura Benuzzi MD [MILANO], Isabella Pezzoli MD [MILANO], Maria Danieli MD [MILANO], Arianna Ciravegna MD [MONZA]) for its efforts in data managing and statistical analysis. The members of the NTF Research Group are: Tiziana Cena [NOVARA], Vincenzo Bagnardi PhD [MILANO], Laura Benuzzi MD [MILANO], Isabella Pezzoli MD [MILANO], Maria Danieli MD [MILANO], and Arianna Ciravegna MD [MONZA].
Compliance with ethical standards
Conflict of interest
The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.
Ethical approval was no necessary because of the retrospective nature of this study.
Informed consent was obtained for all the patients enrolled in clinical research studies.
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424CrossRefGoogle Scholar
Lafaro KJ, Demirjian AN, Pawlik TM (2015) Epidemiology of hepatocellular carcinoma. Surg Oncol Clin N Am 24:1–17CrossRefGoogle Scholar
Ruzzenente A, Guglielmi A, Sandri M et al (2012) Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study. J Gastrointest Surg 16:301–311 (discussion 311)CrossRefGoogle Scholar
Qi X, Tang Y, An D et al (2014) Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. J Clin Gastroenterol 48(5):450–457Google Scholar
De Carlis L, Di Sandro S, Centonze L et al (2016) Liver-allocation policies for patients affected by HCC in Europe. Curr Transplant Rep 3:313–318CrossRefGoogle Scholar
Ota K, Teraoka S, Kawai T (1995) Donor difficulties in Japan and Asian countries. Transplant Proc 27:83–86Google Scholar
Ho M-C, Huang G-T, Tsang Y-M et al (2009) Liver resection improves the survival of patients with multiple hepatocellular carcinomas. Ann Surg Oncol 16:848–855CrossRefGoogle Scholar
Garancini M, Pinotti E, Nespoli S et al (2016) Hepatic resection beyond Barcelona clinic liver cancer indication: when and how. World J Hepatol 8:513–519CrossRefGoogle Scholar
Forner A, Gilabert M, Bruix J, Raoul J-L (2014) Treatment of intermediate-stage hepatocellular carcinoma. Nat Rev Clin Oncol 11:525–535CrossRefGoogle Scholar
Kapitanov T, Neumann UP, Schmeding M (2015) Hepatocellular carcinoma in liver cirrhosis: surgical resection versus transarterial chemoembolization—a meta-analysis. Gastroenterol Res Pract 2015:696120CrossRefGoogle Scholar
Jianyong L, Lunan Y, Wentao W et al (2014) Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection? Medicine 93:e180CrossRefGoogle Scholar
Lin C-T, Hsu K-F, Chen T-W et al (2010) Comparing hepatic resection and transarterial chemoembolization for barcelona clinic liver cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice? World J Surg 34:2155–2161CrossRefGoogle Scholar
von Elm E, Altman DG, Egger M et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808CrossRefGoogle Scholar
Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefGoogle Scholar
European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRefGoogle Scholar
Mazzaferro V, Llovet JM, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43CrossRefGoogle Scholar
Verslype C, Rosmorduc O, Rougier P, ESMO Guidelines Working Group (2012) Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii41–vii48CrossRefGoogle Scholar
Guerrini GP, Gerunda GE, Montalti R et al (2014) Results of salvage liver transplantation. Liver Int 34:e96–e104CrossRefGoogle Scholar
Felli E, Cillo U, Pinna AD et al (2015) Salvage liver transplantation after laparoscopic resection for hepatocellular carcinoma: a multicenter experience. Updates Surg 67:215–222CrossRefGoogle Scholar
Di Sandro S, Bagnardi V, Najjar M et al (2018) Minor laparoscopic liver resection for hepatocellular carcinoma is safer than minor open resection, especially for less compensated cirrhotic patients: propensity score analysis. Surg Oncol 27:722–729CrossRefGoogle Scholar
Sharma R, Gibbs JF (2010) Recent advances in the management of primary hepatic tumors refinement of surgical techniques and effect on outcome. J Surg Oncol 101:745–754CrossRefGoogle Scholar
Day RW, Brudvik KW, Vauthey J-N et al (2016) Advances in hepatectomy technique: toward zero transfusions in the modern era of liver surgery. Surgery 159:793–801CrossRefGoogle Scholar
Torzilli G, Belghiti J, Kokudo N et al (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers. Ann Surg 257:929–937CrossRefGoogle Scholar
Kim H, Ahn SW, Hong SK et al (2017) Survival benefit of liver resection for Barcelona clinic liver cancer stage B hepatocellular carcinoma. Br J Surg 104:1045–1052CrossRefGoogle Scholar
Cucchetti A, Djulbegovic B, Tsalatsanis A et al (2015) When to perform hepatic resection for intermediate-stage hepatocellular carcinoma. Hepatology 61:905–914CrossRefGoogle Scholar
Shah SA, Cleary SP, Wei AC et al (2007) Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 141:330–339CrossRefGoogle Scholar
Lafaro K, Grandhi MS, Herman JM, Pawlik TM (2016) The importance of surgical margins in primary malignancies of the liver. J Surg Oncol 113:296–303CrossRefGoogle Scholar
Di Sandro S, Sposito C, Lauterio A et al (2018) Proposal of prognostic survival models before and after liver resection for hepatocellular carcinoma in potentially transplantable patients. J Am Coll Surg 226:1147–1159CrossRefGoogle Scholar